Lars Henrik Høie
Keine laufenden Positionen mehr
Karriereverlauf von Lars Henrik Høie
Ehemalige bekannte Positionen von Lars Henrik Høie
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Nutri Pharma ASA
Nutri Pharma ASA Miscellaneous Commercial ServicesCommercial Services Nutri Pharma ASA engages in the development of soy technology for the treatment and prevention of life-style related diseases such as obesity, elevated cholesterol levels and diabetes. The firm's products include Nutrilett (weight management), Abacor (cholesterol reduction) and Abalon (for diabetes treatment). It develops a range of products based on soy ingredients, using isolated soy protein with high levels of isoflavones and cotyledon soy fibre. The company was founded in 1993 and is headquartered in Oslo, Norway | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1993 | - |
Gründer | 01.01.1993 | - | |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Direktor/Vorstandsmitglied | 25.07.2011 | - |
Vorsitzender | 26.07.2011 | - |
Ausbildung von Lars Henrik Høie
University of Oslo | Doctorate Degree |
Statistik
International
Norwegen | 4 |
Operativ
Director/Board Member | 1 |
Chairman | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |
Nutri Pharma ASA
Nutri Pharma ASA Miscellaneous Commercial ServicesCommercial Services Nutri Pharma ASA engages in the development of soy technology for the treatment and prevention of life-style related diseases such as obesity, elevated cholesterol levels and diabetes. The firm's products include Nutrilett (weight management), Abacor (cholesterol reduction) and Abalon (for diabetes treatment). It develops a range of products based on soy ingredients, using isolated soy protein with high levels of isoflavones and cotyledon soy fibre. The company was founded in 1993 and is headquartered in Oslo, Norway | Commercial Services |
- Börse
- Insiders
- Lars Henrik Høie
- Erfahrung